Please assess the completion status of the following clinical trial:

Trial Title: Resistance STEMI Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Age between 18 and 75 years~* Presentation within 12 hours after the onset of complaints~* Acute ST-elevation myocardial infarction with a total ST segment deviation ≥5 mm~* Able to give and understand informed consent~* Culprit lesion in a proximal or mid-segment of one of the major coronary arteries (diameter ≥2,5 mm), which is stented successfully~* Stable condition after stenting~* One or more additional lesions in one or more different coronary arteries, mandating FFR measurement +/- PPCI during the subacute phase~Exclusion Criteria:~* Age \< 18 years or \> 75 years~* Cardiogenic shock or pre-shock, determined by the clinician~* Patients with previous myocardial infarction in the culprit artery or with previous bypass surgery~* Very tortuous or calcified coronary arteries~* Long or complex PPCI~* Severe concomitant disease or conditions with a life expectancy of less than 1 year~* Inability to understand and give informed consent~* Known myocardial diseases such as severe left ventricular hypertrophy or cardiomyopathy~* Pregnancy~* Severe conduction disturbances necessitating implantation of a temporary pacemaker~* Contraindications for MRI (claustrophobia, ferromagnetic metal fragments in the body)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Study arm (Type: OTHER): The study arm will undergo absolute flow and resistance measurements immediately after PPCI of the culprit artery

Based on this trial design, predict the completion outcome and termination type (if applicable).